SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced an

Related Keywords

Ohio ,United States ,Columbus ,Ohio State University ,Joseph Bednash ,Daniel Jones ,Jeffrey Horowitz ,Linda Saif ,Richard Gumina ,Emily Caldwell ,Negin Goodarzi ,Julia Faraone ,Kai Xu ,Rama Mallampalli ,Eugene Oltz ,Shan Lu Liu ,Claire Carlin ,Ohio State Infectious Diseases Institute ,Ohio State Comprehensive Cancer Center ,National Center ,Translational Sciences ,Robertj Anthony Fund For Cardiovascular Research ,Department Of Microbial Infection ,National Institutes Of Health ,Pathogens Program ,Centers For Disease ,World Health Organization ,Ohio State College Of Veterinary Medicine ,Retrovirus Research ,Veterinary Biosciences ,Ohio State ,Microbial Infection ,Disease Control ,Middle East ,Emerging Pathogens Program ,Infectious Diseases ,National Institutes ,Advancing Translational Sciences ,Glenn Barber Fellowship ,Veterinary Medicine ,Cardiovascular Research ,Comprehensive Cancer Center ,Yi Min Zheng ,